Fallbericht
Suspected Drug-Induced Hepatocellular Injury Following Use of an Unregulated Injectable Product Marketed as Retatrutide: A Case Report
Cureus · 02.11.2026
DOI: 10.7759/cureus.119014 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 02.11.2026. Verfasst von Ahmed Elhassan und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Elhassan, A., Ali, I., Mohamed, A., & Mahgoub, A. (2026). Suspected Drug-Induced Hepatocellular Injury Following Use of an Unregulated Injectable Product Marketed as Retatrutide: A Case Report. Cureus. https://doi.org/10.7759/cureus.119014
Vancouver
Elhassan A, Ali I, Mohamed A, Mahgoub A. Suspected Drug-Induced Hepatocellular Injury Following Use of an Unregulated Injectable Product Marketed as Retatrutide: A Case Report. Cureus. 2026. doi:10.7759/cureus.119014
BibTeX
@article{Elhassan2026,
author = {Elhassan, Ahmed and Ali, Isra and Mohamed, Abu-Bekr and Mahgoub, Ahmed},
title = {Suspected Drug-Induced Hepatocellular Injury Following Use of an Unregulated Injectable Product Marketed as Retatrutide: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.119014}
}
EUVIMED